We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAPS
251
DELISTED
WM TECHNOLOGY INC A
MAPS
$46K ﹤0.01%
28,562
FOA icon
252
Finance of America Companies
FOA
$198M
$45K ﹤0.01%
3,058
-27,776
-90% -$440K
CPAAW
253
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
$45K ﹤0.01%
222,795
-400
-0.2% -$99
SNDL icon
254
Sundial Growers
SNDL
$318M
$44K ﹤0.01%
20,310
FLYX.WS icon
255
flyExclusive Inc Warrants
FLYX.WS
$43K ﹤0.01%
+340,434
New +$48.5K
CPARW
256
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$43K ﹤0.01%
354,722
+4,700
+1% +$796
FEXDR
257
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
$42K ﹤0.01%
278,599
+107,555
+63% +$11.9K
IGACW
258
DELISTED
IG Acquisition Corp. Warrant
IGACW
$42K ﹤0.01%
283,090
+34,769
+14% +$4.11K
PACB icon
259
Pacific Biosciences
PACB
$357M
$41K ﹤0.01%
+84,400
New +$484K
JWSM.WS
260
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$41K ﹤0.01%
414,317
+146,261
+55% +$23.8K
AAC.WS
261
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$40K ﹤0.01%
350,765
-31,119
-8% -$5.33K
TYGOW
262
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
$40K ﹤0.01%
+201,365
New +$27.5K
NFNT.WS
263
DELISTED
Infinite Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFNT.WS
$39K ﹤0.01%
229,558
+400
+0.2% +$89
LAAAW
264
DELISTED
Lakeshore Acquisition I Corp. Warrant
LAAAW
$38K ﹤0.01%
278,912
+1,810
+0.7% +$345
BSLKW
265
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$37K ﹤0.01%
633,872
+233,732
+58% +$17.7K
DAVE icon
266
Dave Inc
DAVE
$4B
$36K ﹤0.01%
+3,125
New +$57.7K
BFAC.WS
267
DELISTED
Battery Future Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
BFAC.WS
$36K ﹤0.01%
330,387
+75,087
+29% +$11.3K
RWODR
268
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
$36K ﹤0.01%
371,291
+100
+0% +$10
ALTIW
269
DELISTED
AlTi Global Inc Warrant
ALTIW
$36K ﹤0.01%
126,598
+19,398
+18% +$9.92K
AWINW
270
DELISTED
AERWINS Technologies Inc Warrant
AWINW
$35K ﹤0.01%
393,122
+278,622
+243% +$26.7K
ASCAR
271
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
$35K ﹤0.01%
294,698
+1,000
+0.3% +$111
WPCB.WS
272
DELISTED
Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCB.WS
$35K ﹤0.01%
550,028
+405,117
+280% +$57.5K
BLND icon
273
Blend Labs
BLND
$338M
$34K ﹤0.01%
+143,700
New +$408K
PDYNW icon
274
Palladyne AI Corp Warrants
PDYNW
$177K
$34K ﹤0.01%
135,881
-63,308
-32% -$26.1K
SDSTW
275
Stardust Power Inc Warrant
SDSTW
$34K ﹤0.01%
563,290
+27,293
+5% +$3.09K

Similar funds

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.